Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
The May edition of TechTalk at Leiden Bio Science Park was a reminder that women’s health is not a niche. It’s a vital priority for the future of healthcare. Hosted in collaboration with Rijksmuseum Boerhaave, the session sparked conversations that continue to resonate, shedding light on overlooked gaps and new approaches in science and medicine.
The event brought together experts across research, clinical care, and technology, all focused on advancing women’s health through smarter innovation and more inclusive thinking. From early human development and sex-specific cardiology to next-generation diagnostics and a new standard for birth care, the speakers challenged the status quo and emphasized the need for research that reflects real-world diversity.
Highlights included:
Veerle Michels (Amsterdam UMC) – on using 3D imaging to understand early human development
Jin A. (LUMC Women’s Heart Clinic) – on the urgency of sex-specific care in cardiology
Arianne van Koppen & Ruth van Veelen (TNO) – on developing a holistic, data-driven approach to women’s health
Oda Heerema-Snoep (LiGalli) – on their intravaginal MedRing, enabling targeted diagnostics and drug delivery
Alex Vernooij (Concord Neonatal) – on designing a “shock-free” birth for every baby
These conversations reminded us that progress happens when we ask the right questions—and truly listen to the answers.
We’re proud to create a platform for bold ideas and open dialogue, and we look forward to continuing this important conversation across the Park and beyond.
December 8, 2025, The share of female professors is increasing, but the growth remains limited. With 34.2%, Leiden University ranks in the national top three, according to the...
Leiden, December 6, 2025, 12:15 PM – by Robbert Beurse - Every day, around 70,000 people in the Netherlands experience a migraine attack. The condition ranks among the five most...
The meteorological winter has begun, and with it, the flu season. Yet there is hope: the Leiden-based biotech company Leyden Labs is working on a promising innovation that could...